HCV Advocate

  • Home
    • About Us
      • Mission
      • History
    • Site Map
    • Contact Us
  • Newly Diagnosed
  • Treatment
    • HCV Medications
      • Quick Reference Guide – Medications FDA Approved
      • Drug Pipeline – Monthly Report
      • Clinical Trials Reference Guide
    • Current Treatments
      • HepC Medications Blog
      • Easy C’s (Treatment)
      • HCSP Facts (Treatment)
    • Current Treatment – Side Effects
      • Treatment Side Effect Management (Easy Cs)
      • Treatment Side Effect Management (HCSP Fact Sheets)
    • FDA-Approved Prescribing Information (Package Inserts)
    • Drug Pipeline and Conference Coverage
    • Treatment-Related Guides
  • Fact Sheets
    • Easy C’s
      • Extrahepatic Manifestations of HCV
      • General Information about Hepatitis
      • HCV Populations
      • Hepatitis C Tests
      • Hepatitis C Tests- with Voiceover
      • Natural and Alternative Medicine
      • Staying Healthy
      • Symptoms
      • Transmission/Prevention
      • Treatments (Current)
      • Treatments – with Voiceover
      • Side Effect Management (Easy C’s)
    • Harm Reduction Series
    • HCSP Fact Series
      • Advocacy
      • Alcohol
      • A Brief History of HCV
      • Being an Effective Healthcare Consumer
      • Extrahepatic Manifestations of HCV
      • General Information
      • HCV Diagnostic Tools
      • HCV Disease Progression
      • HCV Education and Support
      • HCV Populations
      • HCV Transmission and Prevention
      • HCV and Women
      • Hepatitis C Around the World
      • Treatment Side Effect Management
      • The Liver
      • Wellness
    • FAQ’s
    • Guides
      • Basic Information
      • Managing HCV
      • Topic Specific
      • Treatment-Related Guides
      • Work-Related
    • HIV-HCV Coinfection
      • General Information (Coinfection)
      • Disease Progression (Coinfection)
      • HIV/HCV Coinfection Guides
      • Immune System (Coinfection)
      • HIV/HCV Coinfection Facts
      • Related Conditions (Coinfection)
      • Transmission / Prevention (Coinfection)
      • Treatment (Coinfection)
      • Wellness (Coinfection)
    • Chinese
    • Tattoos
      • Tattoo Aftercare
      • Flash Art
      • Temporary Tattoos
      • Tattoo Inks
      • Pain and Blood
      • Tattoo Coverup
      • Tattoo Machine
      • Autoclave
      • Tattoo Prices
      • Tattoo Make up
      • The Official Blog of the Hepatitis and Tattoos Website
      • Yantra Tattoos
      • Tattoo Removal
      • Tattoo Infection
      • What is a Tattoo
  • Resources
    • Hepatitis C Basics Blog
    • Disability & Benefits
    • Glossaries
      • Herbal Glossary
      • Medical Glossary
      • Extrahepatic Manifestations Glossary
      • Harm Reduction Glossary
    • Helpful Links
      • Pharmaceutical Resources
      • US & Canada Links
      • Australasia Sites
      • European Sites
      • India Sites
      • South American Sites
      • Online Support Forums, Listservs and Chat Rooms
    • Support Groups
    • Hepatitis C Community and Events
    • Training Re-Certification
    • Training Materials
    • Print Ready Educational Materials
      • Baby Boomer Postcard
      • Don’t Get More than a Tattoo Postcard
      • The Basics – English
      • The Basics – Spanish
  • Español
    • Datos Sencillos
      • Información General
      • Grupos de Población
      • Cómo Mantenerse Sanos
      • Medicina Natural y Alternativa
      • Pruebas
      • Sintomas
      • Transmisión / Prevención
      • Tratamiento
    • Artículos del HCSP
      • Información General
      • Progresión de la enfermedad
      • Tratamiento de los Efectos Secundarios
      • La Transmisión y Prevención
    • Preguntas Más Frecuentes
  • HBV
    • HBV Guide
    • HBV Advocate Blog
    • Easy B Fact Sheets
      • General Info
      • Diagnostic Tools & Markers
      • Disease Management
      • Staying Healthy
      • Transmission / Prevention
      • Treatment
    • HBV Fact Series
      • General Information (HBV)
      • Diagnostic Tests (HBV)
      • Disease Management (HBV)
      • Education & Support (HBV)
      • Transmission / Prevention (HBV)
      • Treatment (HBV)
  • Newsletter
    • 2018 Archive
    • 2017 Archive
    • 2016 Archive
    • 2015 Archive
    • 2014 Archive
    • 2013 Archive
  • Donate!

HCV Advocate Eblast: December 1, 2016

November 30, 2016 By Alan Franciscus

Check out what we have in store for you in the December Newsletter

Newsletter_banner_new

Dear Advocaters,

It’s hard to believe that it’s December and 2017 is right around the corner.  It’s been a busy year at the HCV Advocate and this month’s issue is no exception.  Lucinda K. Porter RN and I have each picked some of our favorite abstracts from this year’s AASLD’s Liver Meeting.  Matthew Zielske’s article continues on the theme of research to discuss turning research and education into practice.

  • The Five by Alan Franciscus – I have picked five abstracts that I think are some of the most interesting including alcohol and treatment, HBV reactivation during and after HCV treatment, patient descriptions of fatigue (my favorite), curing HCV and diabetes, and the cost of generic direct-acting antiviral medications.
  • HealthWise by Lucinda K. Porter—AASLD – Lucinda has picked various abstracts such as payer treatment restrictions, pre-existing liver disease treatment and outcomes of breast cancer, hepatitis C reactivation in patients with cancer, alcohol and treatment outcome, fatigue, HAV and HBV vaccination in people with liver disease, and surveillance and screening of liver cancer.
  • Under the Umbrella by Matthew Zielske –The challenges of proving what we know – Matthew writes about the importance of communication and some of the discrimination that people face when seeking information and medical care.
  • HCV Advocate Pipeline has been updated with phase 2 information about AbbVie’s combination of glecaprevir plus pibrentasvir to treat genotype 1, 3,4, 5, and 6.  Hint – very high cure rates.
  • What’s Up!
    • Check out our new Easy C fact sheets:
      • What are RAVs
      • Taking HCV Meds  – Adherence
    • We have updated our HCSP fact sheet:
      • Adherence to HCV Therapy

Coming Next Month

  • The Top News Stories of 2016
  • A New Fact Sheet Series:  Harm Reduction

Many thanks for your continued support,

Alan and the HCV Advocate team

Click here to read this issue.

Share This Page
Facebooktwittergoogle_plusredditpinterestlinkedintumblrmailFacebooktwittergoogle_plusredditpinterestlinkedintumblrmail

Follow Us
FacebooktwitterrssFacebooktwitterrss

Filed Under: Eblast, Main Blog, Newsletter Tagged With: eblast

HCV Advocate Eblast: November 1, 2016

October 31, 2016 By Alan Franciscus

Check out what we have in store for you in the November Newsletter

Newsletter_banner_new

Dear Advocaters,

Here we are in the fall and only days away from the election—finally!  Anyway, this issue of the HCV Advocate newsletter is, in my opinion, one of our best.  I hope you think so too!

Please find the following articles:

  • HealthWise – Talking to Your Doctor About Hepatitis C Treatment, Getting What’s Best for You  by Lucinda K. Porter, RN — Lucinda discusses the importance of working with your doctor, how to fight insurance denials, helpful resources, and other important information.
  • HCV Drugs  by Alan Franciscus — I discuss two studies—the first one is about Gilead’s salvage therapy to treat the small percentage of people who do not respond to the current standard of care.  The second study is an  AbbVie study that treated HCV genotype 1b patients for 8 weeks that resulted in very high cure rates.
  • Snapshots by Alan Franciscus — I reviewed two studies:  The first one is a study conducted in the Veterans Affairs National Health Care System that evaluated all of the current (at that time) direct-acting antivirals (DAAs) medications to understand the cure rates and the ‘real-world’ results vs. results from the clinical trials.
  • Under the Umbrella  HCV Community Education – Teaching and Learning by Matthew Zielske—Matthew shares his ideas and experiences as an educator.  Matthew has conducted our Train-the-Trainer Workshops in Indiana and Kentucky and we hope to expand the workshops throughout the United States in 2017.
  • HCV Drug Pipeline Our Drug Pipeline has been updated with the information about the Gilead data from this month’s newsletter.
  • What’s Up!
    • Check out our new Easy C fact sheet on the importance of testing for hepatitis B before initiating HCV direct-acting antiviral therapy.
    • We have also added many resources to our Trainers page including 2 slide sets—a short presentation and the longer that one we include in our Train-the-Trainer workshops.  We also have a list of resources.

Don’t forget to join us for coverage of the Liver Meeting.  We will be covering it on our News and Pipeline blog and in the December 2016 and January 2017 HCV Advocate Newsletter.

Cheers,

Alan and the staff of the HCV Advocate Newsletter

Click here to read this issue.

Share This Page
Facebooktwittergoogle_plusredditpinterestlinkedintumblrmailFacebooktwittergoogle_plusredditpinterestlinkedintumblrmail

Follow Us
FacebooktwitterrssFacebooktwitterrss

Filed Under: Eblast, Main Blog, Newsletter Tagged With: eblast

  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 15
  • Next Page »

Search this site . . .

If your Search results are not what you need, be sure to check out our Glossaries!

Share HCV Advocate

Facebooktwittergoogle_plusredditpinterestlinkedintumblrmailFacebooktwittergoogle_plusredditpinterestlinkedintumblrmail

Follow HCV Advocate

FacebooktwitterrssFacebooktwitterrss

Watch Our New Video

Click here to listen to a real patient talk about her journey from diagnosis to treatment to cure

Click on the image to go to PackHealth.com/hcv
and use promo code HCV2017

RSS HCV Advocate News & Pipeline Blog

  • Viral Hepatitis Updates from the HHS Office of HIV/AIDS and Infectious Disease Policy April 20, 2018
  • Reduced Risk of Hepatocellular Carcinoma in DAA-Treated HCV Infection | Hannah Dellabella April 20, 2018
  • County tops state in hepatitis C cases per capita | Ken de la Bastide | The Herald Bulletin April 20, 2018
  • Talal’s Hepatitis C Therapies Study Wins BTC Clinical Research Award April 19, 2018

Weekly Special Topic

Water

Drinking water while on treatment will help you while on treatment

Click on the image to view/download the pdf


Click here to read interesting previous Weekly Special Topics.

Share This Page
Facebooktwittergoogle_plusredditpinterestlinkedintumblrmailFacebooktwittergoogle_plusredditpinterestlinkedintumblrmail

Follow Us
FacebooktwitterrssFacebooktwitterrss

Subscribe to the Eblast

Featured Posts!

HCV Advocate Eblast: April 1, 2018

Check out what we have in store for you in the April Newsletter Dear Advocaters, In this issue of the HCV Advocate newsletter we have SnapShots, … [More...]

More Posts from this Category

Events!

Click here for information about events related to HCV.

Do you have an event you'd like us to list for you?  Go to this page to enter the information.

 

Follow Us

FacebooktwitterrssFacebooktwitterrss

Copyright © 2018 · Hepatitis C Support Project · Design by CD Mazoff